Showing results (371-380 of 3,017) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|August 21, 2007
Camptothecin: therapeutic potential and biotechnologySupaart Sirikantaramas, Takashi Asano, Hiroshi Sudo, et al.Current Pharmaceutical Biotechnology|August 21, 2007
Tropane and nicotine alkaloid biosynthesis-novel approaches towards biotechnological production of plant-derived pharmaceuticalsKirsi-Marja Oksman-CaldenteyCurrent Pharmaceutical Biotechnology|August 21, 2007
Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnologySupaart Sirikantaramas, Futoshi Taura, Satoshi Morimoto, et al.Current Pharmaceutical Biotechnology|February 23, 2012
Antidote control of aptamer therapeutics: the road to a safer class of drug agentsK M Bompiani, R S Woodruff, R C Becker, et al.Current Pharmaceutical Biotechnology|February 23, 2012
Black widow spider (Latrodectus mactans) antivenom in clinical practiceAndrew A MonteCurrent Pharmaceutical Biotechnology|February 23, 2012
Antidotes for acute cyanide poisoningStephen W Borron, Frederic J BaudCurrent Pharmaceutical Biotechnology|February 23, 2012
Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibioticsJames H DoroshowCurrent Pharmaceutical Biotechnology|January 31, 2012
Development of stable lyophilized protein drug productsRichard L Remmele, Sampathkumar Krishnan, William J CallahanCurrent Pharmaceutical Biotechnology|January 31, 2012
Treating impaired cognition in schizophreniaH M Ibrahim, C A TammingaCurrent Pharmaceutical Biotechnology|January 31, 2012
From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophreniaP A Gaspar, M L Bustamante, L E Rojo, et al.Pageof 302